Valerie Azoulay

Title: Valerie Azoulay: Innovator in Pharmaceutical Formulations

Introduction

Valerie Azoulay is a notable inventor based in Pardes Hana, Israel. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on benzimidazole derivatives. With a total of 3 patents to her name, her work has the potential to enhance the stability and effectiveness of various medications.

Latest Patents

One of her latest patents is a stable benzimidazole formulation. This innovative composition involves a benzimidazole derivative, such as Omeprazole, which does not require a separating layer between the active compound and the enteric coating layer. Instead, the enteric coating layer is applied as a solution with a pH value of at least 6.5, preferably ranging from about 7 to about 10, directly onto the benzimidazole derivative substrate. This method allows for the direct coating of the substrate without the need for an intermediate layer. Additionally, the enteric coating can be applied in an aqueous solution, eliminating the necessity for organic solvents. This formulation not only maintains the stability of the benzimidazole derivative during storage but also protects the product as it passes through the acidic environment of the stomach. The interaction between the enteric coat and the alkaline core is effectively eliminated, ensuring a more reliable pharmaceutical product.

Career Highlights

Valerie has worked with reputable companies such as Dexcel Ltd. and Dexcel Pharma Technologies Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations and formulations.

Collaborations

Throughout her career, Valerie has collaborated with professionals like Erica Lahav, a legal representative, and Raffael Lahav. These collaborations have likely enriched her work and contributed to her success in the field.

Conclusion

Valerie Azoulay stands out as an innovative inventor in the pharmaceutical industry, particularly with her advancements in benzimidazole formulations. Her contributions are poised to make a significant impact on medication stability and effectiveness.